Skip to main content
Stock Expert AI
Stock of the Day INTERMEDIATE ✨ AI Enhanced

Axsome Therapeutics Surges 18.96% to $177.00 Following Bullish Analyst Update

AI-generated editorial content. For informational purposes only. Not financial advice.

Biopharmaceutical company Axsome Therapeutics (AXSM) experienced a significant jump in shares today, driven by an optimistic analyst rating and price target revision.

📅
🕑 3 min read

🎯

MoonshotScore AI Ratings

Our AI analyzes fundamentals, momentum, and sentiment to score each stock 0-100.

AXSM 68/100
UNF 56/100
CTAS 49/100
NEE 56/100
GILD 55/100
Axsome Therapeutics Surges 18.96% to $177.00 Following Bullish Analyst Update

This name deserves a closer look. Axsome Therapeutics (AXSM) saw its shares surge +18.96% today, closing at $177.00. This significant upward movement immediately positioned the biopharmaceutical company as a top performer at the close of 2025, drawing considerable investor attention. The catalyst for this impressive daily performance appears to be a recent

Related Tickers

👥 Compiled from 200+ financial sources
🧠 AI-enhanced analysis with MoonshotScore
Fact-checked against live market data
👁 Editorial Transparency
🧠Content generated by AI editorial engine
👤Sam Rivera is an AI editorial voice of Stock Expert AI
Editorially supervised by Sedat ANAK
🕑Last updated:

Frequently Asked Questions

Why did Axsome Therapeutics (AXSM) stock surge today?

Axsome Therapeutics (AXSM) stock surged 18.96% today, closing at $177.00, following a bullish analyst update and a revised price target. This positioned the biopharmaceutical company as a top performer.

What was the catalyst for AXSM's recent stock jump?

The significant jump in AXSM shares was primarily driven by an optimistic analyst rating and an upward revision of the company's price target, attracting considerable investor attention.

Where can I find more news on Axsome Therapeutics (AXSM)?

You can find more news and analysis on Axsome Therapeutics (AXSM) by visiting financial news websites, checking their dedicated stock pages, or exploring biopharmaceutical sector updates.

Related Resources

Related Sectors & Industries

Related Investment Themes


You Might Also Like

Explore More Market Intelligence

Evidence & Sources

  • Data sources used on Stock Expert AI include FMP (Financial Modeling Prep), Alpaca, Finnhub, Alpha Vantage, and SEC filings where available.
  • Definitions follow standard investing terminology, with key terms explained inline in plain language where useful.
  • Financial data is refreshed regularly from real-time and delayed market feeds.
  • This page is educational and does not constitute investment advice.
  • All analysis is generated by AI models and should be verified with independent research.

Last updated: 2026-07-05